3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
3
Sarcoma, Ewing
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Interventions
Oxaliplatin
6
Capecitabine
6
Fluorouracil
5
Leucovorin
4
trastuzumab deruxtecan
3
pembrolizumab
3
cemiplimab
3
Cisplatin
3
zolbetuximab
2
fludarabine
2
durvalumab
2
Trastuzumab
2
Ramucirumab
2
Paclitaxel
2
Cyclophosphamide
2
tucatinib
1
repotrectinib
1
paricalcitol
1
lenvatinib
1
enzalutamide
1
darolutamide
1
atezolizumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
Vinorelbine
1
Transurethral Resection of Prostate
1
Taxes
1
Radiosurgery
1
Radiofrequency Ablation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.